Safety and Efficacy of IBI306 in HeFH Patients

Clinical trial NCT04179669 · COMPLETED

Trial details

NCT number: NCT04179669
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Heterozygous Familial Hypercholesterolemia

Start date: 2019-12-20
Primary completion: 2021-06-30
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.